免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

BTL-703-2

K号: K200382 · 2021-01-06

申请人Btl
决定日期2021-01-06
产品代码NGX
咨询委员会PM 请注意,由于您没有提供具体的医疗设备监管文本,我无法进行翻译。请提供具体的文本内容,以便我能够按照您的要求进行翻译。
决定实质等同

器械摘要

BTL-703-2 is the device name listed in this FDA 510(k) record. The listed applicant is Btl. It received FDA 510(k) clearance on 2021-01-06 under 510(k) number K200382. The device is classified under product code NGX. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the BTL-703-2?

BTL-703-2 is a medical device that received FDA 510(k) clearance on 2021-01-06. The listed applicant is Btl. The 510(k) number is K200382.

When did BTL-703-2 receive FDA 510(k) clearance?

BTL-703-2 received FDA 510(k) clearance on 2021-01-06, under 510(k) number K200382.

Who is the listed applicant for BTL-703-2?

The FDA 510(k) record lists Btl as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BTL-703-2?

The FDA product code for BTL-703-2 is NGX.

列明Btl为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:NGX)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑